openPR Logo
Press release

Gout Therapeutics Market | Demand, Scope and New Market Opportunities Explored to 2025; Teijin Pharma Ltd.; Novartis AG; Takeda Pharmaceutical Company Ltd.; Savient Pharmaceuticals

02-25-2019 12:31 PM CET | Health & Medicine

Press release from: Crystal Market Research - Healthcare

Gout Therapeutics Market 2025

Gout Therapeutics Market 2025

Crystal Market Research (CMR) render to you profound details in respect to leading participants, regions, application and type of the Gout Therapeutics Market which is estimated to encounter substantial growth over the forecast period 2016 - 2025.

Gout Therapeutics Market Opportunities 2025:
Major players in market are shifting their focus towards more serious gout cases in order to meet unmet medical needs of drugs for effective treatments. NSAIDs and Colchicines are expected to attract large investment due to their increasing adoption and success rate in treating acute as well as chronic gout disease. Many players have collaborated for research and development to develop more efficient drug for the treatment of gout diseases. The market will be dominated by urate lowering agents that has ability to prevent gout disease by blocking genes responsible for gout disease. With FDA approval of Zurampic (in 2015) to reduce uric acid level in blood and other new drugs in clinical trials will bring in huge opportunities for key players in the market.

Book Your Sample Copy of the Report here @ https://www.crystalmarketresearch.com/report-sample/HC055

Competitive Analysis:
Major players comprise GlaxoSmithKline plc; Merck& Co. Inc.; AstraZeneca plc; Teijin Pharma Ltd.; Novartis AG; Takeda Pharmaceutical Company Ltd.; Savient Pharmaceuticals; and Regeneron Pharmaceuticals.

Gout therapeutic market is segmented as follows –
By Product Type:
Colchicines
Corticosteroids
NSAIDs
Urate-lowering Agents

By Disease Condition:
Acute Gout
Chronic Gout

Market Analysis-
Market Segmentation
Market Sizing and Forecasting
Strategic Recommendations

Competitive Intelligence-
Company Analysis
Market Share Analysis
Industry Benchmarking

Regional Insights:
North America: U.S, Canada, Mexico
Europe: Germany, France, UK, Italy, Spain, Rest of Europe
Asia-Pacific: Japan, China, Australia, India, South Korea, Rest of Asia Pacific
Rest of the World: Brazil, South Africa, Saudi Arabia, United Arab Emirates, Others

Industry Trend Analysis:
The global gout therapeutics market is estimated to be around $8 billion by 2025. This market has witnessed tremendous growth in last few years due to preface of various regenerative drugs and escalated acceptance of these biologics for treatment. This can be attributed to their capability to generate potent anti-inflammatory action which speeds up treatment time. Furthermore, many other drugs are currently under clinical trials which are likely to be launched in coming years which will play an important role in the market growth. Rising incidence of gout due to changes in lifestyle, growing alcohol consumption, increasing obesity and ingestion of some specific medications will drive the growth of this market.

Ask Questions to Expertise at @ https://www.crystalmarketresearch.com/send-an-enquiry/HC055

Table of Contents:
1. Introduction
2. Executive Summary
3. Market Overview
...
7. Company Profiles
7.1. Takeda Pharmaceutical Company Ltd.
7.1.1. Business Overview
7.1.2. Product Portfolio
7.1.3. Key Financials
7.1.4. Strategic Developments

7.2. Novartis
7.2.1. Business Overview
7.2.2. Product Portfolio
7.2.3. Key Financials
7.2.4. Strategic Developments

7.3. Savient Pharmaceuticals
7.3.1. Business Overview
7.3.2. Product Portfolio
7.3.3. Key Financials
7.3.4. Strategic Developments

7.4. Regeneron Pharmaceuticals
7.4.1. Business Overview
7.4.2. Product Portfolio
7.4.3. Key Financials
7.4.4. Strategic Developments

7.5. AstraZeneca plc
7.5.1. Business Overview
7.5.2. Product Portfolio
7.5.3. Key Financials
7.5.4. Strategic Developments

7.6. Horizon Pharma plc
7.6.1. Business Overview
7.6.2. Product Portfolio
7.6.3. Key Financials
7.6.4. Strategic Developments

7.7. BoehringerIngelheim
7.7.1. Business Overview
7.7.2. Product Portfolio
7.7.3. Key Financials
7.7.4. Strategic Developments

7.8. Merck & Co. Inc
7.8.1. Business Overview
7.8.2. Product Portfolio
7.8.3. Key Financials
7.8.4. Strategic Developments
Continued...

Reason To Buy This Report:
We provide Expert consultants and analysts who are exclusively expert in their respective domains. We are employee-centric and hire the passionate and the best individuals in the industry. This radically particular capability helps us discover the latest trends and market intelligence information, which is distinct and exclusive from the competition.

Our experts provide top to bottom coverage of the market from various aspects right from global market scenario to future trends and opportunities. Our research study methodologies are designed in such a way that our clients are able to find the answers they’re looking for, in the way they want.

We are a customer-centric association, which efforts to enhance and augment values to the customer’s business by rendering the most insightful research.

For More Discounts Offers on Report @ https://www.crystalmarketresearch.com/check-discount/HC055

About Crystal Market Research:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gout Therapeutics Market | Demand, Scope and New Market Opportunities Explored to 2025; Teijin Pharma Ltd.; Novartis AG; Takeda Pharmaceutical Company Ltd.; Savient Pharmaceuticals here

News-ID: 1613859 • Views:

More Releases from Crystal Market Research - Healthcare

Viral Vector And Plasmid Dna Manufacturing Market Outlook 2019 | Business Development | Research Report 2025
Viral Vector And Plasmid Dna Manufacturing Market Outlook 2019 | Business Develo …
Crystal Market Research Present Advance research on - Viral Vector And Plasmid Dna Manufacturing Market, approximates that the Viral Vector And Plasmid Dna Manufacturing Industry size is anticipated to flourish at a significant CAGR in the future. The Viral Vector and Plasmid DNA Manufacturing Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Viral vectors and plasmid DNA manufacturing usually incorporates
Medical Digital Imaging Systems Market | Research Report 2019-2025 | Major Companies, Shimadzu, Koninklijke Philips N.V, Hitachi, GE Healthcare
Medical Digital Imaging Systems Market | Research Report 2019-2025 | Major Compa …
Crystal Market Research Present Advance research on "Medical Digital Imaging Systems Market", approximates that the Medical Digital Imaging Systems Industry size is anticipated to flourish at a significant CAGR in the future. The Medical Imaging is the process and technique of making the visual portrayals of the inside of the body for the purpose of medical intervention and clinical analysis, just as visual portrayal of the functioning of certain tissues (physiology)
Medical Device Complaint Management Market | Research Report 2019-2025 | Major Companies, MasterControl, IQVIA, Biovia, Sparta Systems
Medical Device Complaint Management Market | Research Report 2019-2025 | Major C …
Crystal Market Research Present Advance research on "Medical Device Complaint Management Market", approximates that the Medical Device Complaint Management Industry size is anticipated to flourish at a significant CAGR in the future. The manufacturers of medical gadget must keep record and also track the complaints of customer as per the Quality System Regulation (QSR) characterized in the 21 CFR Part 820. Furthermore, the FDA Part 803 guidelines need the firms
Veterinary Molecular Diagnostics Market | Research Report 2019-2025 | Major Companies, HealthGene Corporation, Thermo Fisher Scientific Inc, Bioneer, IDEXX Laboratories Inc
Veterinary Molecular Diagnostics Market | Research Report 2019-2025 | Major Comp …
The Universal Veterinary Molecular Diagnostics Market is anticipated to observe supported development over the foreseen period. The major development factor for the growth of Veterinary Molecular Diagnostics is the positive development in the beverage sector. Moreover, expanding canned food preference and increment in extra cash of the customers is the primary factors which are driving the market. Moreover, high recovery and recycling rate of the metal cans is anticipated to

All 5 Releases


More Releases for Gout

Chronic Gout Market Trends, Therapeutics, and Growth Opportunities
Chronic gout is a progressive form of arthritis characterized by elevated uric acid levels, leading to severe joint pain, inflammation, and long-term joint damage. This condition affects millions worldwide, often resulting in impaired mobility and reduced quality of life. With rising prevalence due to lifestyle changes, aging populations, and dietary habits, the Chronic Gout market is witnessing a surge in demand for advanced therapeutics, early diagnostics, and patient management solutions. Download
Chronic Gout Market Massive Growth opportunity Ahead
Introduction Chronic gout is a form of arthritis characterized by recurrent attacks of severe pain, swelling, and inflammation in the joints, often due to the accumulation of uric acid crystals. This condition typically affects the big toe but can also impact other joints, including the knees, elbows, and wrists. Uric acid, a by-product of purine metabolism, accumulates in the body due to overproduction or underexcretion by the kidneys, leading to hyperuricemia
Gout Market Innovations in Pain Management and Treatment
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Gout Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many
Gout Therapeutics Market Analysis By Drug Class (Nonsteroidal Anti-inflammatory …
Report Summary The global gout therapeutics market was valued at USD 2.78 Billion in 2021 and is expected to grow at a CAGR of 13.7% during the forecast period 2023-2032. Gout Therapeutics Market Introduction The deposition of monosodium crystals (MSU) into the distal joints and peripheral tissues results in gout, an inflammatory arthritic disease. Gout is a typical type of painful inflammatory arthritis. One joint is typically affected at a time (often
Global Gout Drugs Market Analysis (2020-2025)
Global Info Research offers a latest published report on Gout Drugs Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Gout Drugs Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/reports/371311/gout-drugs Market
Gout Therapeutics Market Emerging Trends And Forecast By 2025
Global Gout Therapeutics Market: Snapshot The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications. Patients with multiple episodes of severe gout attacks every year or with